Antiretroviral Treatment Gaps and Adherence Among People with HIV in the U.S. Medicare Program
AIDS and Behavior
Authors
Pengxiang Li, Girish Prajapati, Zhi Geng, Vrushabh P. Ladage, Jean Marie Arduino, Dovie L. Watson, Robert Gross, Jalpa A. Doshi
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
JAMA Network OpenSeptember 27, 2024 -
Skepticism Calibration Disorder—The New Public Health Crisis
JAMA Network OpenSeptember 4, 2024 -
Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments
JAMA NetworkAugust 19, 2024 -
Using machine learning to unveil relevant predictors of adherence to recommended health-protective behaviors during the COVID-19 pandemic in Denmark
International Association of Applied PsychologyJune 8, 2024 -
Remote Blood Pressure Monitoring With Social Support for Patients With Hypertension: A Randomized Clinical Trial
JAMA Network OpenJune 3, 2024 -
Participant perspectives on incentives for TB preventative therapy adherence and reduced alcohol use: A qualitative study
PLOS Global Public HealthApril 24, 2024 -
B-OK: A Visual and Tactile Tool for HIV Treatment Adherence Support in a United States Urban Center
medRxivMarch 1, 2024 -
Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)
Journal of the American Heart AssociationJanuary 19, 2024 -
Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine
JCO Oncology PracticeJanuary 18, 2024 -
Estimating The Impact Of Out-Of-Pocket Cost Changes On Abandonment Of HIV Pre-Exposure Prophylaxis
Health AffairsJanuary 8, 2024 -
Detection of Medication Taking Using a Wrist-Worn Commercially Available Wearable Device
JCO Clinical Cancer InformaticsDecember 21, 2023 -
Financial Incentives for Reduced Alcohol Use and Increased Isoniazid Adherence During Tuberculosis Preventive Therapy Among People With HIV in Uganda: An Open-Label, Factorial Randomised Controlled Trial
The Lancet Global HealthDecember 1, 2023